Clinical trial

A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to Metformin

NCT00684528

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2008-06-01

PhasePHASE3

Study timeline

Study start (unknown)2008-06-01Date precision: month

Registry last updated2012-03-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Type 2unresolved

Interventions

Metformin 1500 mg dailyDRUG

Metformin + Janufer (Janumet)DRUG

Sponsors & collaborators

Meir Medical Centerlead sponsor

Clalit Health Servicescollaborator

Mapped research locations

Tel AvivIsrael1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00684528 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.